OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
10 hedge funds and large institutions have $1.25M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SIM
1
Spark Investment Management
New York
| $511K | 13,900 | +13,900 | New |
|
|
HCMT
2
Highland Capital Management (Texas)
Dallas,
Texas
| $471K | 12,800 | +12,800 | New |
|
3
Morgan Stanley
New York
| $107K | 2,899 | +2,899 | New |
|
|
OSAM
4
O'Shaughnessy Asset Management
Stamford,
Connecticut
| $77K | 2,099 | +2,099 | New |
|
5
Bank of America
Charlotte,
North Carolina
| $37K | 1,000 | +1,000 | New |
|
6
Wells Fargo
San Francisco,
California
| $12K | 325 | +325 | New |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $11K | 300 | +300 | New |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $11K | 305 | +305 | New |
|
9
UBS Group
Zurich,
Switzerland
| $8K | 218 | +218 | New |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| $7K | 200 | +200 | New |
|